Healthcare / BiotechnologyUpdated 2026-05-10 22:07 UTC

CPH/ZEAL stock hub

CPH/ZEAL has a live ticker hub with the latest available market, valuation, profitability, growth, ownership, and risk indicators.

Browse stocks

CPH/ZEALis not in this month’s coverageGet our monthly research letter — no spam

Fair value midpoint

n/a

Fair value pending

Upside to midpoint

n/a

Based on latest report

Confidence

n/a

Data quality and model convergence

Market cap

24.1B

Copenhagen Stock Exchange

Market data

Live price

Current market quote for this ticker.

Current price

CPH/ZEAL

In the news

Latest news · CPH/ZEAL

Recent company headlines from major financial publishers.

—

Fetching the latest headlines.

—

Fetching the latest headlines.

—

Fetching the latest headlines.

Calendar

Next earnings

Upcoming earnings date and setup when available.

Upcoming

DateLoading

Window—

EPS estimate—

Revenue estimate—

Sector context

Where the current metrics sit

Percentiles come from the backend screener cohort cache for the ticker's country and sector.

Forward P/E24.5

P25 14.6P50 19.5P75 24.2

Trailing P/E3.8

P25 11.8P50 20.8P75 32.9

ROE56.2

P25 -4.6P50 11.3P75 24.2

ROIC2,303.7

P25 -8.1P50 8.5P75 13.1

Benchmarks - 1M

S&P 500n/a

Nasdaq Compositen/a

Dow Jones Industrial Averagen/a

Russell 2000n/a

Indicator catalog

All CPH/ZEAL market and fundamental indicators

A searchable catalog of the available market, valuation, profitability, growth, balance-sheet, ownership, and analyst metrics for this ticker.

Available fields

202

Groups with data

Currency

DKK

Showing 202 of 202 available metrics for this ticker.

Profile and market data

Ticker identity, listing, currency, market cap, and source dates.

Metric	Value
Country	Denmark
Country code	DK
Employees	501
Employees Change	146%
Employees Change Percent	41.13
Enterprise value	DKK 10.1B
Exchange	Copenhagen Stock Exchange
Financial currency	DKK
First seen	2026-05-10
Industry	Biotechnology
Isin	DK0060257814
Last refreshed	2026-05-10
Market cap	DKK 24.1B
Price	DKK 341
Price currency	DKK
Rev Per Employee	16,986,875x
Sector	Healthcare
Sic	2836
Symbol	cph/ZEAL
Website	https://www.zealandpharma.com

Valuation

Multiples, yields, enterprise-value ratios, and valuation checks.

Metric	Value
Earnings Yield	26.53%
EV Earnings	1.57x
EV/EBIT	1.48x
EV/EBITDA	1.48x
EV/FCF	1.59x
EV/Sales	1.09x
FCF yield	26.23%
Forward P/E	24.55x
P/B ratio	1.67x
P/E ratio	3.82x
P/S ratio	2.61x

Profitability

Margins, returns on capital, cash conversion, and quality metrics.

Metric	Value
EBIT Margin	73.41%
EBITDA Margin	73.58%
FCF margin	68.43%
Gross margin	99.99%
Gross Profit	DKK 9.2B
Gross Profit Growth	17,558.95%
Gross Profit Growth Q	325%
Gross Profit Growth3 Y	342.48%
Gross Profit Growth5 Y	104.87%
Net Income	DKK 6.4B
Net Income Growth Years	1%
Pretax Margin	75.13%
Profit Margin	69.21%
Profit Per Employee	DKK 11.8M
Profitable Years	1
ROA	34.72
Roa5y	-10.72
ROCE	45.54
ROE	56.16
Roe5y	-41.05
ROIC	2,303.7
Roic5y	-24.85

Growth

Revenue, earnings, cash-flow, and forward growth indicators.

Metric	Value
Cagr10y	10.74%
Cagr15y	11.19%
Cagr1y	-24.07%
Cagr3y	15.37%
Cagr5y	11.69%
EPS Growth Years	1
Revenue Growth	16,519.65x
Revenue Growth Q	325x
Revenue Growth Quarters	4x
Revenue Growth Years	1x
Revenue Growth3 Y	342.49x
Revenue Growth5 Y	92.83x

Financial strength

Debt, cash, solvency, accounting-quality, and balance-sheet signals.

Metric	Value
Asset Turnover	DKK 0.76
Assets	DKK 15.3B
Cash	DKK 14.5B
Current Assets	DKK 15B
Current Liabilities	DKK 404M
Debt	DKK 414M
Debt EBITDA	DKK 0.06
Debt Equity	DKK 0.03
Debt FCF	DKK 0.07
Equity	DKK 14.5B
Interest Coverage	260.3
Liabilities	DKK 832M
Long Term Assets	DKK 283M
Long Term Liabilities	DKK 428M
Net Cash	DKK 14.1B
Net Cash By Market Cap	DKK 58.3
Net Cash Growth	72.45%
Net Debt EBITDA	DKK -2.07
Net Debt Equity	DKK -0.97
Net Debt FCF	DKK -2.22
Tangible Book Value	DKK 14.4B
Tangible Book Value Per Share	DKK 204
WACC	7.28

Liquidity

Current-asset coverage and working-capital efficiency metrics.

Metric	Value
Current ratio	37.17
Net Working Capital	DKK 175M
Quick ratio	36.4
Working Capital	DKK 14.6B
Working Capital Turnover	DKK 0.8

Dividends and buybacks

Dividend yield, payout, buybacks, and shareholder-yield indicators.

Metric	Value
Buyback Yield	-4.13%

Performance and technicals

Returns, volatility, beta, momentum, RSI, and moving-average context.

Metric	Value
10Y total return	177.4%
1Y total return	-24.06%
200-day SMA	407.4
3Y total return	53.56%
50-day SMA	303.7
50-day SMA vs 200-day SMA	50under200
5Y total return	73.82%
All Time High	972
All Time High Change	-64.9%
All Time High Date	2024-07-10
All Time Low	37.5
All Time Low Change	809.87%
All Time Low Date	2011-11-22
ATR	18.58
Beta	0.56
Beta1y	2.1
Beta2y	1.54
Ch YTD	-26.84
High	345.5
High52	556
High52 Date	2025-11-20
High52ch	-38.63%
Low	325.4
Low52	233.5
Low52 Date	2026-03-09
Low52ch	46.12%
Ma50ch	12.36%
Price vs 200-day SMA	-16.25%
RSI	63.06
RSI Monthly	40.75
RSI Weekly	45.21
Sharpe ratio	-0.24x
Sortino ratio	-0.23
Total Return	-4.13%
Tr YTD	-26.84
Tr15y	390.94%
Tr1m	23.22%
Tr1w	10.42%
Tr3m	-16.23%

Analyst estimates

Ratings, targets, revisions, and forward estimate fields.

Metric	Value
Operating Income	DKK 6.8B
Operating margin	73.41

Ownership and float

Institutional, insider, float, short-interest, and share-count fields.

Metric	Value
Float	56,743,573%
Net Borrowing	-25,162,000
Shares Insiders	0.42%
Shares Institutions	33.42%
Shares Out	70,649,560
Shares Qo Q	0.36%
Shares Yo Y	4.13%

Other indicators

Additional ticker metrics that do not fit the primary research groupings yet.

Metric	Value
Adjusted FCF	DKK 6.2B
Average Volume	399,020.5x
Bv Per Share	204.8
CAPEX	DKK -37.4M
Ch10y	177.4
Ch15y	390.9
Ch1m	23.22
Ch1w	10.42
Ch1y	-24.06
Ch3m	-16.23
Ch3y	53.56
Ch5y	73.82
Ch6m	-20.09
Change	-1.1%
Change From Open	-1.24
Close	345
Days Gap	0.14
Depreciation Amortization	14,947,000
Dollar Volume	165,256,466.8
Earnings Date	2026-05-07
EBIT	DKK 6.8B
EBITDA	DKK 6.8B
EPS	DKK 89.42
F Score	6
FCF	DKK 6.3B
FCF EV Yield	62.91x
FCF Per Share	DKK 89.51
Financing CF	-385,182,000
Fiscal Year End	December
Founded	1,997
Graham Number	641.89383
Graham Upside	88.13
Income Tax	DKK 547.1M
Investing CF	-2,919,506,000
Is Primary Listing	1
Last Earnings Date	2026-05-07
Last Report Date	2026-03-31
Ma150	408.6
Ma150ch	-16.5%
Ma20	309.4
Ma20ch	10.27%
Net CF	3,072,508,000
Next Earnings Date	2026-08-13
Open	345.5
P FCF Ratio	3.81
P OCF Ratio	3.79
Position In Range	78.61
Ppne	164,000,000
Price Date	2026-05-08
Price EBITDA	DKK 3.55
Ptbv Ratio	1.67
Relative Volume	1.24x
Revenue	9,240,860,000x
SBC By Revenue	1.35x
Share Based Comp	124,890,000
Tax By Revenue	5.92x
Tax Rate	7.88%
Tr6m	-20.09%
Volume	484,339
Z Score	24.53

Fast facts

Decision checkpoints

A compact product layer over the same report payload.

Risk gate

n/a

Named kill scenarios are reviewed before any bullish rating can stand.

Moat score

n/a

Business quality stays separate from stock attractiveness.

Forward P/E

n/a

Valuation uses the full report model stack, not a single multiple.

Next action

Research pending

Final action steps are kept in the recommendation tab.

Income

Does CPH/ZEAL pay a dividend?

Capital-return profile for this ticker.

Performance

CPH/ZEAL stock returns vs the market

Total return (incl. dividends) compared to S&P 500.

Ownership

Who owns CPH/ZEAL?

Insider, institutional, and short-interest positioning.

Institutional ownership

+33.4%

Share of float held by funds and institutions

Insider ownership

+0.4%

Stake held by company insiders. Higher generally signals alignment.

Short interest

n/a

Float sold short by bearish positioning

Y/Y dilution

+4.1%

Negative means the company is buying back shares.

Technical

CPH/ZEAL momentum and risk profile

RSI, moving-average stack, beta, and risk-adjusted return.

RSI (14)

63.1

Neutral momentum band

Price vs 200-day MA

-16.3%

50/200-day relationship not available

Beta (5Y)

0.56

Less volatile than the market

Sharpe ratio

-0.24

Risk-adjusted return — higher is better; >1.0 is solid.

Questions

About CPH/ZEAL

Hub-level FAQ points readers to the deeper analysis pages.

What is the current cph/ZEAL stock rating?

cph/ZEAL is currently shown with the latest rating in the latest report. The hub links directly to the full analysis surface where the rating, fair-value bridge, risks, and scorecard are documented together.

Where can I read the full cph/ZEAL analysis?

The full report lives at /stocks/cph/ZEAL/analysis. The bare ticker page is a product hub that summarizes the latest read and sends readers into the relocated analysis tabs without making the analysis surface depend on the hub.

What fair-value range is used for cph/ZEAL?

The latest report frames cph/ZEAL around the latest fair-value range. Treat that range as the entry point, then check the valuation, sensitivity, and bear-case tabs before making an investment decision.

How often is the cph/ZEAL page updated?

The hub updates with the latest published stock report and live backend market data. The analysis pages remain reachable under /analysis, so a hub rollback does not remove the report reader.